Koen Dockx

Charles River Laboratories (Netherlands) — Netherlands

Medicine · Health Sciences

8h-index341citations19works3.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(8), HIV Research and Treatment(4), Immunotherapy and Immune Responses(4), Immune Cell Function and Interaction(4), Alzheimer's disease research and treatments(3)

Publications19 total

AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level
Frontiers in Immunology·2025· 3 citedOpen Access
Robust isolation protocol for mouse leukocytes from blood and liver resident cells for immunology research
PLoS ONE·2024Open Access
Correction for Van Gulck et al., “A truncated HIV Tat demonstrates potent and specific latency reversal activity”
Antimicrobial Agents and Chemotherapy·2024Open Access
mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model
Vaccines·2024· 12 citedOpen Access
Sustained Liver HBsAg Loss and Clonal T- and B-Cell Expansion upon Therapeutic DNA Vaccination Require Low HBsAg Levels
Vaccines·2023· 5 citedOpen Access
Sustained liver HBsAg loss and clonal T and B cell expansion upon therapeutic DNA vaccination require low HBsAg levels
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Sustained liver HBsAg loss and clonal T and B cell expansion upon therapeutic DNA vaccination require low HBsAg levels
2023Open Access
A truncated HIV Tat demonstrates potent and specific latency reversal activity
Antimicrobial Agents and Chemotherapy·2023· 13 citedOpen Access
Sustained liver HBsAg loss and clonal T and B cell expansion upon therapeutic DNA vaccination require low HBsAg levels
2023· 1 citedOpen Access
AAV-HBV mouse model replicates immune exhaustion patterns of chronic HBV patients at single-cell level
2023· 1 citedOpen Access
A truncated HIV Tat demonstrates potent and specific latency reversal activity
2023· 4 citedOpen Access
Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo
Journal of Alzheimer s Disease·2018· 40 citedOpen Access
Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau
Acta Neuropathologica Communications·2018· 21 citedOpen Access
A common antigenic motif recognized by naturally occurring human VH5–51/VL4–1 anti-tau antibodies with distinct functionalities
Acta Neuropathologica Communications·2018· 24 citedOpen Access
Common antigenic motif recognized by human VH5-51/VL4-1 tau antibodies with distinct functionalities
2018Open Access
[P4–047]: ANTI‐TAU ANTIBODY PROFILING FOR PASSIVE IMMUNIZATION THERAPY: COMPARING SEEDS DERIVED FROM TRANSGENIC ANIMALS AND HUMAN BRAIN TISSUE
Alzheimer s & Dementia·2017· 1 cited
Expression and Purification of Dengue Virus NS5 Polymerase and Development of a High-Throughput Enzymatic Assay for Screening Inhibitors of Dengue Polymerase
Methods in molecular biology·2013· 14 cited
1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C Virus
Journal of Virology·2010· 38 citedOpen Access
Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors
Journal of Virology·2008· 164 citedOpen Access

Frequent Co-authors

Ellen Van Gulck(11), Wim Pierson(8), Isabel Nájera(8), Nádia Conceição‐Neto(7), Dorien De Pooter(6), Ben De Clerck(6), Matthias Beyens(6), Liese Aerts(6), M. Borgers(5), Kristof Van Kolen(5), Marc Mercken(5), Vinod Krishna(5), Daniel Boden(4), Maurizio Vacca(4), Birgit Voeten(4), Lore Verschueren(4), Mathias Vandenberk(4), Ewoud De Troyer(4), Kato Verwilt(4), Carl Van Hove(4)